282.5: Cancer stage and treatment patterns in kidney transplant recipients compared with non-transplant patients in a multicenter hospital tumor registry.
Laia Oliveras, L. Pareja, Josepa Ribes, Gemma Osca et autres
0 citationsTransplantation
Núria Lloberas
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
129Publications signalées
3071Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Renal Transplantation Outcomes and TreatmentsOrgan Transplantation Techniques and OutcomesPharmacological Effects and Toxicity StudiesCytomegalovirus and herpesvirus researchChronic Kidney Disease and Diabetes
Publications récentes
P4.876: From fixed dosing to AUC-guided monitoring: Optimizing mycophenolate mofetil therapy in kidney transplant recipients.
Núria Lloberas, Anna Vidal‐Alabró, Núria Montero, Edoardo Melilli et autres
0 citationsTransplantation
292.6: Hidden interaction: Dulaglutide significantly alters immunosuppressant pharmacokinetics after kidney transplantation.
Núria Montero, Ana Coloma, Laia Oliveras, Gema Cerezo et autres
0 citationsTransplantation
Tacrolimus Conversion in CYP3A5*1 Expressers: From Immediate-Release to LCP Formulation
Anna Vidal‐Alabró, Pere Fontova, Zeyar Mohammed Ali, Beatriz Fernández-Alarcón et autres
0 citationsTherapeutic Drug Monitoring
Optimizing Dose Conversion from IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study
Zeyar Mohammed Ali, Beatriz Fernández-Alarcón, Pere Fontova, Anna Vidal‐Alabró et autres
0 citationsPharmaceutics
State of Art of Dose Individualization to Support tacrolimus drug monitoring: What’s Next?
Núria Lloberas, Beatriz Fernández-Alarcón, Anna Vidal‐Alabró, Helena Colom
12 citationsTransplant International
Optimizing Dose Conversion From IR-Tac to LCP-Tac Formulations in Renal Transplant Recipients: A Population Pharmacokinetic Modeling Study
Zeyar Mohammed Ali, Beatriz Fernández-Alarcón, Pere Fontova, Anna Vidal‐Alabró et autres
0 citationsPreprints.org
A Population Pharmacokinetic Model and Dosing Algorithm to Guide the Tacrolimus Starting and Follow-Up Dose in Living and Deceased Donor Kidney Transplant Recipients
Marith I. Francke, Sebastiaan D. T. Sassen, Núria Lloberas, Helena Colom et autres
7 citationsClinical Pharmacokinetics
Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients at high risk of delayed graft function
Laia Oliveras, Pamela Lopez‐Vargas, Edoardo Melilli, Sergi Codina et autres
5 citationsCochrane Database of Systematic Reviews
Cancer risks in people on dialysis and kidney transplant recipients: a Catalan cohort study, 2003–21
Laia Oliveras, L. Pareja, Josepa Ribes, Jordi Comas et autres
6 citationsClinical Kidney Journal
Editorial: Women in renal pharmacology 2023
Núria Lloberas, Laure Elens, Brenda C. M. de Winter
0 citationsFrontiers in Pharmacology
Customizing Tacrolimus Dosing in Kidney Transplantation: Focus on Pharmacogenetics
Núria Lloberas, Anna Vidal‐Alabró, Helena Colom
7 citationsTherapeutic Drug Monitoring
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.